| 1. | Recist response evaluation criteria in solid tumors
实体瘤疗效反应的评价标准 |
| 2. | Effect of injection strategy on drug transport in two - dimensional solid tumor
注射方式对二维实体肿瘤中药物输运影响的数值研究 |
| 3. | Clinical analysis of 12 cases of malignant solid tumor and acute leukemia with abmt treatment
自体骨髓移植治疗恶性肿瘤和白血病12例临床分析 |
| 4. | Objective : to study the effect of chemosensitivity test in vitro for solid tumor
目的通过实体瘤体外药敏实验指导化疗方案选择,实现肿瘤化疗个体化。 |
| 5. | Improving safety of adoptive immunotherapy with auto - cytokine - induced killer cells in the patients with malignant solid tumor
恶性实体瘤患者自体细胞因子诱导杀伤细胞过继免疫治疗的安全性改进 |
| 6. | It has been reported that luteolin can inhibit the proliferation of serials of tumor cells including solid tumor , ascties cancer and human myeloid leukemia
研究证实其对多种实体瘤、腹水癌和白血病细胞有显著抑制作用。 |
| 7. | Stem cell - like subpopulation has been isolated and identified from hematopoietic system malignancies and solid tumors , and defined as cancer stem cells
在血液系统恶性肿瘤和实体瘤中均分离和鉴定出具有干细胞特征的细胞群，称之为肿瘤干细胞。 |
| 8. | The sentinel node ( sn ) is defined as the first draining node from the primary lesion and it has proven to be a good indicator of the metastatic status of regional lymph nodes in solid tumors
摘要：信号淋巴结（ sn ）被定义为原发病灶的首站引流淋巴结，是判断实体瘤区域淋巴结转移的良好指征。 |
| 9. | This paper reviews the current research situation of angiostatin , the relationship between angiostatin and angiogenesis of solid tumor and the respect of application in cancer anti - vascular therapy
综述了血管生成抑制素的研究现状，分析了它与实体瘤血管生成的关系，及其在实体瘤抗血管生成治疗中的应用前景。 |
| 10. | Angiostatin is a angiogenesis inhibiting factor derived from tumor , which can potently inhibit endothelial cell proliferation and migration and has an important application value in the treatment of solid tumor
摘要血管生成抑制素是肿瘤衍生的血管生成抑制因子，能有效地抑制血管内皮细胞的增生和迁移，在实体瘤的治疗中有重要的应用价值。 |
